2019-01-16 |
1 |
|
U.S. Patent No. 7,566,729
25. U.S. Patent No. 7,566,729 (“the ‘729 patent”), entitled… U.S. Patent No. 7,767,700
29. U.S. Patent No. 7,767,700 (“the ‘700 patent”), entitled… U.S. Patent No. 8,013,002
35. U.S. Patent No. 8,013,002 (“the ‘002 patent”), entitled… U.S. Patent No. 8,383,150
41. U.S. Patent No. 8,383,150 (“the ‘150 patent”), entitled… U.S. Patent No. 8,609,701
47. U.S. Patent No. 8,609,701 (“the ‘701 patent”), entitled |
External link to document |
2020-01-07 |
22 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700…2019
2 January 2020
1:19-cv-00104
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-01-16 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1 ;7,635,707 B1 ;7,767,700…B1 ;7,910,610 B1. See attachment for additional patent numbers. (lak) (Entered: 01/18/2019)
17 January…2019
2 January 2020
1:19-cv-00104
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |